EURAMOS-1, an international randomised study for osteosarcoma: Results from pre-randomisation treatment Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Bone Neoplasms
  • Osteosarcoma

abstract

  • New models of collaboration are required to successfully conduct trials to improve outcomes of patients with rare cancers; EURAMOS-1 demonstrates achievability. Considerable regulatory, financial and operational challenges must be overcome to develop similar studies in the future. The trial is registered as NCT00134030 and ISRCTN 67613327.

authors

publication date

  • February 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4304379

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdu526

PubMed ID

  • 25421877

Additional Document Info

start page

  • 407

end page

  • 14

volume

  • 26

number

  • 2